Shirazian Shayan, Grant Candace D, Aina Olufemi, Mattana Joseph, Khorassani Farah, Ricardo Ana C
Division of Nephrology, Department of Medicine, Winthrop University Hospital, Mineola, New York, USA.
Department of Clinical Health Professions, St. John's University College of Pharmacy and Health Sciences, Queens, New York, USA.
Kidney Int Rep. 2016 Sep 20;2(1):94-107. doi: 10.1016/j.ekir.2016.09.005. eCollection 2017 Jan.
Depression is highly prevalent and is associated with poor quality of life and increased mortality among adults with chronic kidney disease (CKD), including those with end-stage renal disease (ESRD). However, there are several important differences in the diagnosis, epidemiology, and management of depression between patients with non-dialysis-dependent CKD and ESRD. Understanding these differences may lead to a better understanding of depression in these 2 distinct populations. First, diagnosing depression using self-reported questionnaires may be less accurate in patients with ESRD compared with CKD. Second, although the prevalence of interview-based depression is approximately 20% in both groups, the risk factors for depression may vary. Third, potential mechanisms of depression might also differ in CKD versus ESRD. Finally, considerations regarding the type and dose of antidepressant medications vary between CKD and ESRD. Future studies should further examine the mechanisms of depression in both groups, and test interventions to prevent and treat depression in these populations.
抑郁症在慢性肾脏病(CKD)成人患者中高度流行,且与生活质量低下及死亡率增加相关,包括终末期肾病(ESRD)患者。然而,非透析依赖性CKD患者和ESRD患者在抑郁症的诊断、流行病学及管理方面存在若干重要差异。了解这些差异可能有助于更好地理解这两个不同人群中的抑郁症。首先,与CKD患者相比,使用自我报告问卷诊断ESRD患者的抑郁症可能不太准确。其次,尽管两组中基于访谈的抑郁症患病率约为20%,但抑郁症的风险因素可能有所不同。第三,CKD与ESRD患者抑郁症的潜在机制也可能不同。最后,CKD和ESRD患者在抗抑郁药物的类型和剂量方面的考量也有所不同。未来的研究应进一步研究两组中抑郁症的机制,并测试预防和治疗这些人群抑郁症的干预措施。